Obesity, Appetite Control & Diabetes
Obesity, Appetite Control & Diabetes
Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more
Research Areas
Products Related to Obesity, Appetite Control & Diabetes(354)
- GC90698Eicosapentaenoic Acid-d5 ethyl esterCAS: 2483831-19-0Purity: >99.00%
An internal standard for the quantification of eicosapentaenoic acid ethyl ester
- GC908192,3,7,8-TetrachlorodibenzofuranCAS: 51207-31-9Purity: >90.00%
A polychlorinated dibenzofuran and dioxin
- GC90949Adenosine-5'-O-(3-thiotriphosphate) (sodium salt)CAS: 88453-52-5Purity: >95.00%
A P2Y 11 receptor agonist
- GC91042Tauro-Obeticholic Acid (sodium salt)CAS: 2278141-79-8Purity: >98.00%
An active metabolite of obeticholic acid
- GC91123C18 Ganglioside GM3-d3 (d18:1/18:0-d3) (ammonium salt, synthetic)CAS: 2692623-85-9Purity: >99.00%
An internal standard for the quantification of ganglioside G M3
- GC91449Ipamorelin (acetate)Purity: >98.00%
Ipamorelin is a pentapeptide growth hormone secretagogue (GHS) and GHS receptor 1a (GHS-R1a) agonist.
- GC91480Exendin-4 (3-39) amide (trifluoroacetate salt)Purity: >90.00%
Exendin-4 (3-39) amide is an agonist of glucagon-like peptide 1 receptor (GLP-1R) and an active metabolite of exendin-4 (48-86) amide .
- GC91493Semaglutide Side ChainCAS: 1118767-16-0Purity: >98.00%
Semaglutide side chain is a synthetic intermediate.
- GC91544Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OHCAS: 1662688-20-1Purity: >99.50%
Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH is a building block in the synthesis of the glucagon-like peptide 1 receptor (GLP-1R) agonist semaglutide .
- GC919226,6-Dimethyl-3-(4-methylbenzoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-amineCAS: 1461715-47-8Purity: >95.00%
6,6-Dimethyl-3-(4-methylbenzoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-amine is a glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM).
- GC91977TrkB Agonist Prodrug R13CAS: 1609067-49-3Purity: >95.00%
TrkB agonist prodrug R13 (R13) is a prodrug form of the tropomyosin-related kinase B (TrkB) activator 7,8-dihydroxyflavone.
- GC91981Sergliflozin ACAS: 360775-96-8Purity: >98.00%
Sergliflozin A is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; Ki = 2.39 nM for the human transporter) and an active metabolite of sergliflozin etabonate.
- GC920439(10)-NitrooleateCAS: 1092676-99-7Purity: >95.00%
9(10)-Nitrooleate is a mixture of the nitroalkene endogenous lipid signaling molecules 9-nitrooleate.
- GC92058GLP-1 (7-13) (human, mouse, rat, bovine) (trifluoroacetate salt)Purity: >98.00%
GLP-1 (7-13) (human, mouse, rat, bovine) (trifluoroacetate salt) is a peptide fragment of the endogenous incretin hormone GLP-1.
- GC92079GLP-1 (7-15) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)Purity: >98.00%
Glucagon-like peptide 1 (GLP-1) (7-15) is a peptide fragment of the endogenous incretin hormone GLP-1.
- GC92088GLP-1 (28-36) amide (trifluoroacetate salt)Purity: >98.00%
Glucagon-like peptide 1 (GLP-1) (28-36) amide is a peptide and an active metabolite of the endogenous GLP-1R agonist GLP-1 (7-36) amide.
- GC92093GLP-1 (7-17) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)Purity: >98.00%
Glucagon-like peptide 1 (GLP-1) (7-17) is a peptide fragment of the endogenous incretin hormone GLP-1 .
- GC92095Ac-(D-Arg)-CEH-(D-Phe)-RWC-NH2 (trifluoroacetate salt)Purity: >98.00%
Ac-(D-Arg)-CEH-(D-Phe)-RWC-NH2 is a cyclic peptide and an agonist of melanocortin receptor 4 (MC4R).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC90582 | Perfluorooctanesulfonic Acid | 1763-23-1 | >98.00% | |
A perfluoroalkyl substance | ||||
| GC90698 | Eicosapentaenoic Acid-d5 ethyl ester | 2483831-19-0 | >99.00% | |
An internal standard for the quantification of eicosapentaenoic acid ethyl ester | ||||
| GC90819 | 2,3,7,8-Tetrachlorodibenzofuran | 51207-31-9 | >90.00% | |
A polychlorinated dibenzofuran and dioxin | ||||
| GC90949 | Adenosine-5'-O-(3-thiotriphosphate) (sodium salt) | 88453-52-5 | >95.00% | |
A P2Y 11 receptor agonist | ||||
| GC91037 | ZLY28 | 3004676-77-8 | >90.00% | |
An FXR agonist and inhibitor of FABP1 | ||||
| GC91042 | Tauro-Obeticholic Acid (sodium salt) | 2278141-79-8 | >98.00% | |
An active metabolite of obeticholic acid | ||||
| GC91083 | Tiopronin-Cysteine Disulfide | 77591-18-5 | >95.00% | |
A metabolite of tiopronin | ||||
| GC91123 | C18 Ganglioside GM3-d3 (d18:1/18:0-d3) (ammonium salt, synthetic) | 2692623-85-9 | >99.00% | |
An internal standard for the quantification of ganglioside G M3 | ||||
| GC91449 | Ipamorelin (acetate) | - | >98.00% | |
Ipamorelin is a pentapeptide growth hormone secretagogue (GHS) and GHS receptor 1a (GHS-R1a) agonist. | ||||
| GC91480 | Exendin-4 (3-39) amide (trifluoroacetate salt) | - | >90.00% | |
Exendin-4 (3-39) amide is an agonist of glucagon-like peptide 1 receptor (GLP-1R) and an active metabolite of exendin-4 (48-86) amide . | ||||
| GC91493 | Semaglutide Side Chain | 1118767-16-0 | >98.00% | |
Semaglutide side chain is a synthetic intermediate. | ||||
| GC91544 | Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH | 1662688-20-1 | >99.50% | |
Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH is a building block in the synthesis of the glucagon-like peptide 1 receptor (GLP-1R) agonist semaglutide . | ||||
| GC91922 | 6,6-Dimethyl-3-(4-methylbenzoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-amine | 1461715-47-8 | >95.00% | |
6,6-Dimethyl-3-(4-methylbenzoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-amine is a glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM). | ||||
| GC91929 | KOTX1 | 1788963-83-6 | >95.00% | |
KOTX1 is an inhibitor of aldehyde dehydrogenase 1A3 (ALDH1A3; IC50 = 5.14 nM). | ||||
| GC91933 | E17241 | 1060968-92-4 | >95.00% | |
E17241 is an inducer of the expression of ABCA1, the gene encoding ATP-binding cassette transporter 1; subfamily A (ABCA1). | ||||
| GC91966 | Ppc-1 | 1245818-17-0 | - | |
Ppc-1 is a prenylated quinolinecarboxylic acid originally isolated from P. pseudo-candidum that has diverse biological activities. | ||||
| GC91977 | TrkB Agonist Prodrug R13 | 1609067-49-3 | >95.00% | |
TrkB agonist prodrug R13 (R13) is a prodrug form of the tropomyosin-related kinase B (TrkB) activator 7,8-dihydroxyflavone. | ||||
| GC91981 | Sergliflozin A | 360775-96-8 | >98.00% | |
Sergliflozin A is an inhibitor of sodium-glucose cotransporter 2 (SGLT2; Ki = 2.39 nM for the human transporter) and an active metabolite of sergliflozin etabonate. | ||||
| GC92043 | 9(10)-Nitrooleate | 1092676-99-7 | >95.00% | |
9(10)-Nitrooleate is a mixture of the nitroalkene endogenous lipid signaling molecules 9-nitrooleate. | ||||
| GC92058 | GLP-1 (7-13) (human, mouse, rat, bovine) (trifluoroacetate salt) | - | >98.00% | |
GLP-1 (7-13) (human, mouse, rat, bovine) (trifluoroacetate salt) is a peptide fragment of the endogenous incretin hormone GLP-1. | ||||
| GC92079 | GLP-1 (7-15) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) | - | >98.00% | |
Glucagon-like peptide 1 (GLP-1) (7-15) is a peptide fragment of the endogenous incretin hormone GLP-1. | ||||
| GC92088 | GLP-1 (28-36) amide (trifluoroacetate salt) | - | >98.00% | |
Glucagon-like peptide 1 (GLP-1) (28-36) amide is a peptide and an active metabolite of the endogenous GLP-1R agonist GLP-1 (7-36) amide. | ||||
| GC92093 | GLP-1 (7-17) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) | - | >98.00% | |
Glucagon-like peptide 1 (GLP-1) (7-17) is a peptide fragment of the endogenous incretin hormone GLP-1 . | ||||
| GC92095 | Ac-(D-Arg)-CEH-(D-Phe)-RWC-NH2 (trifluoroacetate salt) | - | >98.00% | |
Ac-(D-Arg)-CEH-(D-Phe)-RWC-NH2 is a cyclic peptide and an agonist of melanocortin receptor 4 (MC4R). | ||||